Bemnifosbuvir

Overview

Bemnifosbuvir (AT-511) is a potent and orally active HCV viral replication inhibitor. Bemnifosbuvir is highly effective in the control of SARS-CoV-2 (COVID-19) infection in vitro ( EC 90 =0.47 μM). Bemnifosbuvir has pangenotypic antiviral activity.

Application

Products | Products > Disease Areas > Infection | Products > Disease Areas > Hepatitis Virus Infection | Products > Disease Areas > Viral Infection | Products > Disease Areas > Hepatitis C Virus Infection | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Infection | Products > Signaling Pathways > HCV | Products > Signaling Pathways > SARS-CoV

Product Information

• Catalog No.: HY-137958A
• CAS No.: 1998705-64-8
• Molecular Formula: C24H33FN7O7P
• Molecular Weight: 581.53
• Purity: 99.00%
• Storage: 4°C, protect from light * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
• Solubility: ≥ 2.5 mg/mL (4.30 mM); Clear solution
• Availability: In-stock

Source

Original product source